Petter Gjersvik

Petter Gjersvik

Auto-generated profile, based on publicly available information

Petter Gjersvik

Institute of Clinical Medicine, University of Oslo, Oslo, Norway

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in JAMA Dermatology
Verified
Journal Article
Open access
PDF file
SRSyed Mohammad Husain Rizvi
Syed Mohammad Husain Rizvi
BABjarte Aagnes
Bjarte Aagnes
HHHallvard Holdaas
Hallvard Holdaas
EGEinar Gude
Einar Gude
KBKristin Muri Boberg
Kristin Muri Boberg
PGPetter Gjersvik
Petter Gjersvik
The high risk of skin cancer after solid organ transplantation is a major clinical challenge and is well documented,1-3 but it is unclear whether the risk has changed during the last decades. In a large and comprehensive study on cancer after organ transplantation in Sweden, the authors report no significant differences in the risk of posttransplant cutaneous squamous cell carcinoma (SCC) between patients who underwent transplantation in the 1980s, 1990s, and 2000s.4 This is in contrast to a smaller Dutch study, primarily analyzing posttransplant SCC as a risk factor for developing noncutaneous cancer5 and in contrast to the clinical experience of dermatologists at several transplantation centers, all reporting a decline in the incidence of SCC among transplant recipients (TRs) who underwent kidney transplantation in recent decades (Jan Nico Bouwes Bavinck, MD, PhD, Leiden University Medical Center, personal communication, February 3, 2017).

1 January 2021 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
KEK.M.A. Endre
K.M.A. Endre
LLL. Landrø
L. Landrø
MLM. LeBlanc
M. LeBlanc
PGP. Gjersvik
P. Gjersvik
KCK.C. Lødrup Carlsen
K.C. Lødrup Carlsen
ERE.M. Rehbinder
E.M. Rehbinder
Summary: BackgroundDiagnosing atopic dermatitis (AD) in infants is challenging.ObjectivesTo determine the incidence and persistence of eczema and AD in infants using the UK Working Party (UKWP) and Hanifin and Rajka (H&R) criteria.MethodsA cohort of 1834 infants was examined clinically at 3, 6 and 12 months of age. AD was diagnosed by UKWP (3, 6 and 12 months) and H&R (12 months) criteria. Logistic regression models were used to assess the relationship between AD and eczema.ResultsEczema was observed in 628 (34·2%) infants (n = 240, n = 359 and n = 329 at 3, 6 and 12 months, respectively), with AD diagnosed in 212 (33·7%) infants with any eczema and in 64/78 (82%) infants with eczema at all three visits. The odds of AD were lower with first presentation of eczema at 6 [odds ratio (OR) 0·33, 95% confidence interval (CI) 0·22–0·48] or 12 months (OR 0·49, 95% CI 0·32–0·74) than at 3 months, and higher in infants with eczema at three (OR 23·1, 95% CI 12·3–43·6) or two (OR 6·5, 95% CI 4·3–9·9) visits vs. one visit only. At 12 months, 156/329 (47·4%) fulfilled the UKWP and/or H&R criteria; 27 (8%) fulfilled the UKWP criteria only and 65 (20%) only the H&R criteria. Of the 129 infants who fulfilled the H&R criteria, 44 (34·1%) did not meet the itch criterion.ConclusionsUsed in combination and at multiple timepoints, the UKWP and H&R criteria for AD may be useful in clinical research but may have limited value in most other clinical settings.

1 September 2023 in JAMA Dermatology
Verified
Journal Article
Open access
PDF file
PGPetter Gjersvik
Petter Gjersvik
RFRagnhild S. Falk
Ragnhild S. Falk
IRIngrid Roscher
Ingrid Roscher
SRSyed Mohammad Husain Rizvi
Syed Mohammad Husain Rizvi
GMGeir Mjøen
Geir Mjøen
TRTrude Eid Robsahm
Trude Eid Robsahm
Patients with cutaneous squamous cell carcinoma (cSCC), globally the second-most common form of skin cancer, frequently develop multiple primary tumors either simultaneously or during follow-up.1 The reported risk of metastasis from cSCC varies, particularly between hospital-based2-6 and population-based studies.7-9 Organ transplant recipients (OTRs) have a very high risk of developing cSCC10-13 and seem to have a greater risk of metastasis from cSCC than immunocompetent patients.14 Studies on the risk of disease-specific death from cSCC, however, are limited both in immunocompetent and immunosuppressed patients.15,16 To increase knowledge on the epidemiology and clinical course of cSCC, we studied the occurrence of a second cSCC, metastasis, and death from cSCC in non-OTRs and OTRs, using population-based data from national registries that span more than 5 decades.

29 August 2014 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
HGH.E. Gustavsen
H.E. Gustavsen
PGP. Gjersvik
P. Gjersvik

7 October 2019 in Tidsskrift for Den norske legeforening
Verified
Journal Article
Open access
PGPetter Gjersvik
Petter Gjersvik
07.10.2019: Språkspalten - Kunnskapsbasert medisin er en lite presis og lite hensiktsmessig oversettelse av evidence-based medicine.

11 June 2020 in Tidsskrift for Den norske legeforening
Verified
Journal Article
Closed access
PGPetter Gjersvik
Petter Gjersvik
11.06.2020: Kronikk - En eksamen i medisinstudiet skal teste kunnskaper og ferdigheter som studentene får bruk for som leger – ikke studentenes evne til å bestå eksamen.